A 12 week, open, randomized, parallel, multicenter study of efficacy, tolerability and safety of hydrochlorothiazide (+) losartan potassium versus amlodipine in essential hypertensive patients
Phase of Trial: Phase IV
Latest Information Update: 19 Apr 2017
At a glance
- Drugs Amlodipine (Primary) ; Losartan/hydrochlorothiazide (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Merck & Co
- 01 Feb 2007 Status changed from in progress.
- 05 Nov 2005 New trial record.